查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2129030

分子腫瘤委員會解決方案市場：按組件、解決方案、癌症類型、最終用途、國家和地區分類－產業分析、市場規模、市場佔有率及2026年至2033年預測

Molecular Tumor Board Solutions Market, By Component, By Solution, By Cancer Type, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 370 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，分子腫瘤委員會 (MTB) 解決方案市值將達到 18.16 億美元，並將在 2026 年至 2033 年期間以 14.2% 的複合年成長率成長。

分子腫瘤委員會 (MTB) 解決方案市場涵蓋軟體平台、臨床決策支援系統、基因組分析工具、資料管理平台以及相關癌症類型，旨在幫助多學科腫瘤團隊評估和管理複雜的癌症病例。這些解決方案整合了基因測序數據、病理學觀察、病歷、生物標記、用藥資訊和其他患者特異性數據，從而提供全面的病例評估和個人化的治療方案。

分子腫瘤委員會解決方案市場 - 市場動態

精準腫瘤學和基因組檢測的日益普及，以及對臨床決策支援日益成長的需求，預計將推動市場需求。

精準腫瘤學和全面基因組分析的日益普及是分子腫瘤委員會（MTB）解決方案市場成長的主要驅動力。基因突變、拷貝數變異、基因融合、生物標記和其他分子異常等，構成了由次世代定序（NGS）和其他尖端分子診斷技術快速發展而產生的日益複雜的資料集。解讀這些結果通常需要多學科專家的參與，包括腫瘤內科醫生、病理學家、分子生物學家、遺傳學家和生物資訊學家。 MTB解決方案透過整合和組織分子和臨床數據，將基因組分析結果與臨床建議、科學文獻、標靶治療和相關臨床試驗聯繫起來，簡化了此流程。這使得跨專業團隊能夠進行更結構化、實證的治療討論。一項對2025年健康評估分析了34項研究，涉及12176名患者，結果顯示20.8%的患者接受了分子腫瘤委員會（MTB）提案的治療，這表明基於MTB的方法在癌症治療中的作用日益增強。

腫瘤學數據的日益成長、多樣性和複雜性推動了對數位化和人工智慧驅動的分子腫瘤學專家組解決方案的需求，這些方案能夠簡化病例準備、減輕行政負擔並提高臨床解讀的準確性。傳統的多學科專家小組（MTB）流程通常需要耗費大量時間和精力來收集和審查患者病歷、基因定序報告、病理觀察、科學文獻、治療建議以及相關的臨床試驗數據，才能進行多學科會診。透過將臨床和分子數據整合到單一平台，數位化MTB平台能夠快速存取相關的患者數據並更有效地進行病例審查，從而幫助克服這些挑戰。此外，人工智慧和進階分析功能的整合還能進一步實現資料聚合、文獻和證據搜尋、生物標記解讀以及其他任務的自動化。

分子腫瘤委員會（MTB）解決方案市場－細分分析：

全球分子腫瘤委員會解決方案市場按組件、解決方案、癌症類型、最終用戶和地區進行細分。

根據解決方案的不同，市場可細分為六大類：臨床決策支援、基因組數據解讀、數據分析、報告和視覺化、患者病例管理以及其他。按解決方案分類，臨床決策支援預計將佔據市場收入的很大一部分。臨床決策支援平台提供必要的數位基礎設施，用於整合患者資料、組織和解讀分子檢測結果、簡化病例準備流程、促進跨學科討論、記錄治療建議以及支援持續的患者追蹤。例如，羅氏的「navify腫瘤委員會臨床中心」提供會議安排和管理病患名單的功能。

分子腫瘤委員會解決方案市場—區域分析

北美地區強大的精準腫瘤學生態系統、完善的基因組檢測基礎設施、廣泛的專業癌症中心網路以及數位化臨床決策支援技術的廣泛應用，共同促成了該地區在分子腫瘤學專家組解決方案市場的主導地位。尤其值得一提的是，美國擁有許多醫療機構、科技公司和腫瘤學專業團體，致力於基因分析、臨床資訊學和分子腫瘤學專家組服務。歐洲市場則受益於其發達的醫療保健體系、前沿的癌症研究能力、大學附屬醫療中心以及精準醫療的日益普及。該地區各國正日益重視分子腫瘤學專家組流程的標準化、加強基因組檢測在常規癌症治療中的整合以及強化臨床、診斷和研究團隊之間的協作。

目錄

第1章：分子腫瘤委員會解決方案市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：分子腫瘤委員會解決方案的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：分子腫瘤委員會解決方案的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 分子腫瘤委員會解決方案市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：分子腫瘤委員會解決方案市場概覽

  • 分子腫瘤委員會解決方案市佔率分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 分子腫瘤委員會解決方案市場：依組件分類

  • 概述
    • 基於細分市場的市場佔有率分析：按組件
    • 軟體
    • 服務

第8章 分子腫瘤委員會解決方案市場：按解決方案分類

  • 概述
    • 基於細分市場的市場佔有率分析：按解決方案
    • 臨床決策支持
    • 基因組數據的解讀
    • 資料分析
    • 報告創建和可視化
    • 患者個案管理
    • 其他

第9章 分子腫瘤委員會解決方案市場：按癌症類型分類

  • 概述
    • 按癌症類型分類的市場佔有率分析：
    • 肺癌
    • 乳癌
    • 結腸癌
    • 骨髓惡性腫瘤
    • 攝護腺癌
    • 黑色素瘤
    • 其他

第10章 分子腫瘤委員會解決方案市場：依最終用途分類

  • 概述
    • 基於細分市場的市佔率分析：依最終用途
    • 醫院
    • 專科癌症中心
    • 研究機構
    • 診斷檢查室
    • 其他

第11章 分子腫瘤委員會解決方案市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第12章：主要供應商分析：分子腫瘤板解決方案產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Roche
    • Tempus AI, Inc.
    • Caris Life Sciences
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • Syapse, Inc.
    • GenomOncology, LLC
    • Molecular Health GmbH
    • SOPHiA GENETICS
    • QIAGEN NV
    • Guardant Health, Inc.
    • Myriad Genetics, Inc.
    • NantHealth, Inc.
    • MedGenome
    • CureMatch
    • Variantyx, Inc.
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7366

Molecular Tumor Board Solutions Market size was valued at USD 1,801.6 Million in 2025, expanding to a CAGR of 14.2% from 2026 to 2033.

The molecular tumor board (MTB) solutions market includes software platforms, clinical decision-support systems, genomic interpretation tools, data-management platforms, and related Cancer Type that enable multidisciplinary oncology teams to evaluate and manage complex cancer cases. These solutions offer thorough case assessment and individualized treatment planning by combining genomic sequencing data, pathology findings, clinical history, biomarkers, medication information, and other patient-specific data.

Molecular Tumor Board Solutions Market- Market Dynamics

Increasing adoption of precision oncology & genomic testing and need for clinical decision support are expected to propel market demand

The increasing adoption of precision oncology and comprehensive genomic profiling is a key factor driving the growth of the molecular tumor board solutions market. Gene mutations, copy-number variations, gene fusions, biomarkers, and other molecular abnormalities are among the increasingly complex datasets produced by the widespread use of next-generation sequencing (NGS) and other cutting-edge molecular diagnostic technologies. Multidisciplinary experts, including as oncologists, pathologists, molecular biologists, geneticists, bioinformaticians, and others, are frequently needed to interpret these results. By integrating and organizing molecular and clinical data and connecting genomic findings with clinical recommendations, scientific literature, targeted medicines, and pertinent clinical trials, MTB solutions facilitate this process. This makes it possible for interdisciplinary teams to have better organized, evidence-based therapy conversations. 20.8% of patients got treatments suggested by molecular tumour boards, according to a 2025 healthcare assessment of 34 research including 12,176 patients, indicating the expanding role of MTB-based techniques in cancer treatment.

Demand for digital and AI-enabled molecular tumour board solutions that can simplify case preparation, lessen administrative workload, and improve clinical interpretation is being driven by the growing volume, diversity, and complexity of oncology data. Prior to multidisciplinary conversations, traditional MTB procedures frequently need a substantial amount of time and effort to gather and examine patient records, genetic sequencing reports, pathology findings, scientific literature, therapeutic recommendations, and pertinent clinical trial data. By consolidating clinical and molecular data into a single setting, digital MTB platforms help to overcome these obstacles by facilitating quicker access to pertinent patient data and more effective case review. Data aggregation, literature and evidence retrieval, biomarker interpretation, and other tasks can be further automated by integrating AI and advanced analytics.

Molecular Tumor Board Solutions Market- Segmentation Analysis:

The Global Molecular Tumor Board Solutions Market is segmented on the basis of Component, Solution, Cancer Type, End-Use, and Region.

The market is divided into six categories based on Solution: clinical decision support, genomic data interpretation, data analytics, reporting & visualization, patient case management, and others. By solution, clinical decision support segment is anticipated to have a considerable revenue share in the market. Clinical decision-support platforms provide the digital infrastructure needed to consolidate patient data, organize and interpret molecular findings, streamline case preparation, facilitate multidisciplinary discussions, document treatment recommendations, and support ongoing patient follow-up. Roche's navify Clinical Hub for Tumor Boards, for example, provides meeting coordination, patient-list management.

Molecular Tumor Board Solutions Market- Geographical Insights

North America's robust precision oncology ecosystem, vast genomic testing infrastructure, extensive network of specialized cancer centres, and widespread adoption of digital clinical decision-support technologies all contribute to the region's dominant position in the molecular tumour board solutions market. Healthcare facilities, technological companies, and oncology-focused groups engaged in genetic interpretation, clinical informatics, and molecular tumour board services are particularly prevalent in the United States. Developed healthcare systems, cutting-edge cancer research skills, university medical centres, and the growing use of precision medicine are what propel the European market. The region's nations are focusing more on standardizing molecular tumour board procedures, enhancing the incorporation of genomic testing into regular cancer treatment, and bolstering cooperation between clinical, diagnostic, and research teams.

India Molecular Tumor Board Solutions Market- Key Insights

India's rising cancer incidence, developing precision-oncology capabilities, improving diagnostic infrastructure, and increased access to genomic testing all contribute to the country's potential as a market for molecular tumor board solutions. With businesses like MedGenome and other specialized providers supporting the adoption of genomic-based cancer assessment and individualized treatment options, the nation is also fortifying its ecosystem of molecular diagnostics and genomic testing. However, a number of obstacles, such as unequal access to sophisticated oncology and the expensive cost of complete genetic sequencing, limit market expansion. The use of MTB solutions is anticipated to grow throughout India's main cancer centers and specialist oncology networks as genomic testing becomes more widely available and digital healthcare infrastructure advances.

Molecular Tumor Board Solutions Market- Competitive Landscape:

The molecular tumor board solutions market is highly competitive and continuously evolving, with participation from healthcare technology companies, diagnostic & genomic-testing providers, oncology software developers, academic medical centers, pharmaceutical companies, and specialized clinical decision-support firms. Market participants are differentiating themselves through advanced genomic interpretation, clinical decision support, workflow automation, electronic health record (EHR) integration, AI-enabled analytics, and seamless data management. A key competitive trend is the shift from basic digital tools for tumor board coordination toward integrated precision-oncology platforms. Patient records, genomic profiles, pathology data, therapy recommendations, scientific literature, and clinical trial data are all being integrated into a single workflow by these platforms.

Recent Developments:

In June 2025, Roche Diagnostics Japan enhanced its navify Tumor Board software to accommodate gene-panel testing for hematological malignancies, broadening the platform's molecular tumor-board capabilities beyond solid-tumor applications.

In May 2025, Tempus announced that 10 abstracts had been selected for presentation at the 2025 ASCO Annual Meeting, showcasing the company's advancements in AI-driven precision oncology and molecularly informed cancer care.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET KEY PLAYERS

  • Roche
  • Tempus AI, Inc.
  • Caris Life Sciences
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Syapse, Inc.
  • GenomOncology, LLC
  • Molecular Health GmbH
  • SOPHiA GENETICS
  • QIAGEN N.V.
  • Guardant Health, Inc.
  • Myriad Genetics, Inc.
  • NantHealth, Inc.
  • MedGenome
  • CureMatch
  • Variantyx, Inc.
  • Others

GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033

  • Software
  • Services

GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY SOLUTION- MARKET ANALYSIS, 2020-2033

  • Clinical Decision Support
  • Genomic Data Interpretation
  • Data Analytics
  • Reporting & Visualization
  • Patient Case Management
  • Others

GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020-2033

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Hematological Malignancies
  • Prostate Cancer
  • Melanoma
  • Others

GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

  • Hospitals
  • Specialized Cancer Centers
  • Research Institutes
  • Diagnostic Laboratories
  • Others

GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Molecular Tumor Board Solutions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Tumor Board Solutions Market Snippet by Component
    • 2.1.2. Molecular Tumor Board Solutions Market Snippet by Solution
    • 2.1.3. Molecular Tumor Board Solutions Market Snippet by Cancer Type
    • 2.1.4. Molecular Tumor Board Solutions Market Snippet by End-Use
    • 2.1.5. Molecular Tumor Board Solutions Market Snippet by Country
    • 2.1.6. Molecular Tumor Board Solutions Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Tumor Board Solutions Key Market Trends

  • 3.1. Molecular Tumor Board Solutions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Tumor Board Solutions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Tumor Board Solutions Market Opportunities
  • 3.4. Molecular Tumor Board Solutions Market Future Trends

4. Molecular Tumor Board Solutions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Tumor Board Solutions Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Molecular Tumor Board Solutions Market Landscape

  • 6.1. Molecular Tumor Board Solutions Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Tumor Board Solutions Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
    • 7.1.2. Software
    • 7.1.3. Services

8. Molecular Tumor Board Solutions Market - By Solution

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Solution, 2025 & 2033 (%)
    • 8.1.2. Clinical Decision Support
    • 8.1.3. Genomic Data Interpretation
    • 8.1.4. Data Analytics
    • 8.1.5. Reporting & Visualization
    • 8.1.6. Patient Case Management
    • 8.1.7. Others

9. Molecular Tumor Board Solutions Market - By Cancer Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Cancer Type, 2025 & 2033 (%)
    • 9.1.2. Lung Cancer
    • 9.1.3. Breast Cancer
    • 9.1.4. Colorectal Cancer
    • 9.1.5. Hematological Malignancies
    • 9.1.6. Prostate Cancer
    • 9.1.7. Melanoma
    • 9.1.8. Others

10. Molecular Tumor Board Solutions Market - By End-Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Specialized Cancer Centers
    • 10.1.4. Research Institutes
    • 10.1.5. Diagnostic Laboratories
    • 10.1.6. Others

11. Molecular Tumor Board Solutions Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Molecular Tumor Board Solutions Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Molecular Tumor Board Solutions Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Molecular Tumor Board Solutions Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Molecular Tumor Board Solutions Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Molecular Tumor Board Solutions Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Molecular Tumor Board Solutions Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Roche
    • 12.2.2. Tempus AI, Inc.
    • 12.2.3. Caris Life Sciences
    • 12.2.4. Illumina, Inc.
    • 12.2.5. Thermo Fisher Scientific Inc.
    • 12.2.6. Syapse, Inc.
    • 12.2.7. GenomOncology, LLC
    • 12.2.8. Molecular Health GmbH
    • 12.2.9. SOPHiA GENETICS
    • 12.2.10. QIAGEN N.V.
    • 12.2.11. Guardant Health, Inc.
    • 12.2.12. Myriad Genetics, Inc.
    • 12.2.13. NantHealth, Inc.
    • 12.2.14. MedGenome
    • 12.2.15. CureMatch
    • 12.2.16. Variantyx, Inc.
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us